ABSTRACT: Adenosine triphosphate-binding cassette transporter A1 (ABCA1) plays an important role in lipid metabolism and is involved in diabetes. We investigated the associations between lipid profiles and an early-onset diabetic phenotype with ABCA1 genotypes among 999 type 2 diabetes mellitus patients in the Han Chinese population of Taiwan. During study enrolment, blood samples were collected by venipuncture from these patients for genomic DNA isolation and serological tests, and data related to the diabetes age of onset were collected using a self-report questionnaire. Four single-nucleotide polymorphisms (SNPs) were selected for genotyping by polymerase chain reaction in each patient. The present study found that the high-density lipoprotein (HDL) levels were significantly different among patients with different genotypes at SNP rs2487039 (p = 0.018). The body mass index (BMI) was also significantly different among patients with different genotypes at SNP rs2487039, rs2230806, and rs200069 (p = 0.009, 0.004, and 0.003, respectively). The polymorphisms at position rs10121901 in ABCA1 were statistically associated with development of early-onset type 2 diabetes mellitus (p = 0.013), with an odds ratio of 0.78 (95% confidence interval: 0.64-0.95). In conclusion, an ABCA1 variant is associated with HDL level, BMI, and early-onset type 2 diabetes mellitus in a specific Taiwanese population.
INTRODUCTION
Type 2 diabetes mellitus (T2DM) and its complications are a significant public health problem. The disease is responsible for blindness, renal replacement therapy, and cardiovascular interventions in a large proportion of patients, all of which have a substantial negative impact on overall health care expenditure and quality of life. The prevalence and incidence of T2DM among young adults has been increasing every year in the last two decades 1, 2 . Studies have shown that early-onset diabetes is associated with an increased risk for complications in comparison to late-onset diabetes and that the development and progression of complications might be more rapid in the earlyonset disease 3 . One hypothesis to explain these www.scienceasia.org observations proposes that the longer disease duration and exposure to adverse risk factors for early-onset T2DM patients lead to diabetes-related complications, with significant morbidity and mortality. Another hypothesis suggests that early diagnosis of T2DM in young subjects identifies an inherently aggressive phenotype that develops more complications than lateonset disease 4, 5 . Current evidence indicates that the risk of developing T2DM is controlled by environmental and genetic factors. Heterogeneity, as a determinant of T2DM development, has been identified by candidate gene and genome-wide association approaches across multiple populations 6, 7 . Obesity is one risk factor for developing T2DM. Several susceptibility genes related to lipid metabolism, such as apolipoprotein A1, lipoprotein lipase 8, 9 , and adiponectin [10] [11] [12] , also have been investigated for their relationship with T2DM, but the results of these studies have been inconsistent.
Adenosine triphosphate-binding cassette transporter A1 (ABCA1) is a 2261-amino acid integral membrane protein that is highly expressed in the liver and tissue macrophages. It is a cell membrane transporter and mediates the efflux of cholesterol, phospholipids, and other lipophilic molecules from cells; transfer of these molecules from peripheral cells to lipid-poor apolipoprotein A1 is the first step in highdensity lipoprotein (HDL) particle formation 13, 14 by a number of metabolically active pathways. In studies of cultured cells, human HDL deficiencies and animal models have shown that ABCA1 is an efficient exporter of cholesterol from macrophages and other cells and is a major determinant of plasma HDL levels. Moreover, ABCA1 may play a key role in HDL metabolism and could be involved in diabetes. One study reports that cholesterol accumulation in pancreatic beta-cells could lead to insulin secretion failure in a mouse model, and may be an important component of lipotoxicity in pancreatic islets 15 .The selective loss of ABCA1 in pancreatic beta-cells leads to age-related progressive impairment in glucose tolerance, even in heterozygous mice 15 . There is genetic evidence that ABCA1 is involved in modulating T2DM in humans. Several ABCA1 polymorphisms and mutations have been reported to decrease HDL cholesterol levels [16] [17] [18] [19] , obesity 16 , and T2DM 20, 21 across multiple ethnic groups. In the Mexican population, subjects with the R230C polymorphism (rs9282541) in the ABCA1 gene have low HDL 19 , increased body mass 16 , elevated haemoglobin A 1c levels, reduced fasting insulin, and early-onset T2DM 22 . Based on these previous observations, we investigated the potential association between variability of polymorphisms in the ABCA1 gene, lipid profiles, and the early-onset diabetic phenotype among the Han Chinese population of Taiwan.
MATERIALS AND METHODS

Patients and data collection
This was a cross-sectional study. A total of 999 T2DM patients over 20 years of age were recruited from China Medical University Hospital (CMUH) in Taiwan. Informed consents were obtained from all patients for this study. Diabetes was diagnosed according to medical records and fasting plasma glucose levels using the American Diabetic association (ADA) criteria 23 . Patients with type 1 diabetes mellitus, gestational diabetes, and maturity-onset diabetes of the young were excluded from this study. All participating patients were of Han Chinese origin as the Han Chinese account for 98% of the Taiwanese population. Data regarding age, sex, age of onset of diabetes mellitus were collected from self-report questionnaires. Based on the ADA recommended age for T2DM, screening of these patients revealed that 281 patients were 20 years but < 45 years of age at the time of diagnosis (early-onset diabetes) and 718 patients were 45 years (late-onset diabetes). Weight, height, waist/hip circumference and blood pressure were measured at the time of enrolment. Blood samples were collected by venipuncture for genomic DNA isolation and serological tests, including fasting glucose, HbA 1c , total cholesterol, triglyceride, HDL-cholesterol and LDL-cholesterol at the time of enrolment. The study was reviewed by the ethics committee of CMUH (IRB No. DMR99-IRB-164-2; approved 15 Nov 2011) and performed according to the tenets of the Declaration of Helsinki for research involving human subjects.
SNP selection and genotyping
We selected four single nucleotide polymorphisms (SNPs) for genotyping, including rs10121901 and rs2487039 in introns, rs2230806 (Arg219Lys) in an exon, and rs200069, with an unknown locus and designated as the official distinctive SNP of the ABCA1 gene. All the selected SNPs were selected in previous studies and exhibit allele frequencies of more than 5% in the Han Chinese population 22, 24 . Linkage disequilibrium (LD) was performed with HAPLOVIEW 4.1, and the result showed LD between rs2487039 and rs2230806 (r 2 = 0.97). For genotyping, genomic DNA was extracted from peripheral blood leukocytes using a genomic DNA kit (Qiagen, Valencia, CA, USA) in accordance with the manufacturer's instruc- tions. Genotyping was performed using an allelespecific extension and ligation assay, according to the manufacturer's instructions (Illumina, Inc., San Diego, CA, USA).
Statistical analysis
Genotype and allele frequency distributions in the polymorphisms of T2DM patients with different phenotypes (early-onset disease, heart disease, and microvascular diseases) were analysed using the χ 2 test or Fisher's exact test for differences in proportions. Mean values of various clinical variables were compared between groups using ANOVA, and post-hoc comparisons were performed with Bonferroni adjustment. Analysis of covariance (ANCOVA) or two-way ANOVA was used to adjust for confounding variables and the possible interactions. The odds ratio (OR) was calculated from genotype frequencies and allelic frequencies with a 95% confidence interval (CI), using unconditional logistical regression. All statistical analyses were conducted using SAS statistical software, version 9.1 (SAS Institute Inc., Cary, NC), and p < 0.05 (two-sided) was considered significant.
RESULTS
The demographic and clinical parameters of the participants are summarized in Table 1 . To investigate the effect of genotype on clinical serology lipid profiles and body mass index (BMI) among T2DM patients, we genotyped four SNPs in the ABCA1 gene. The level of BMI was significantly different among patients with different genotypes at SNP rs2487039, rs2230806, and rs200069 (p = 0.009, 0.004, and 0.003, respectively). For pairwise comparisons, the mean value of BMI was significantly different for the following genotype pairs: between CC genotype and TT genotype at SNP rs2487039, between AA genotype and GG genotype at SNP rs2230806, and between CC genotype and TT genotype at SNP rs200069 (p = 0.007, 0.005, and 0.003 after Bonferroni adjustment, respectively). Additionally, the levels of HDL-cholesterol were significantly different among the T2DM patients with different genotypes at SNP rs2487039 (p = 0.018). Subjects carrying the TC genotype had lower HDL-cholesterol levels than those carrying the TT genotype (p = 0.042 after Bonferroni adjustment). Furthermore, the possible confounding effect from BMI on the association between genotype and HDL level was investigated by ANCOVA analyses. The result showed that the SNP (rs2487039) effect on HDL was still significant (p = 0.019) after adjusting for BMI (p < 0.001) (the interaction term BMI*SNP was not significant; p = 0.806). However, the levels of other lipid serological markers were not significantly different among selected SNPs (Table 2) .
In our database, 28% (n = 281) of the subjects had early-onset T2DM (mean age at diagnosis, 39 ± 5), and 72% (n = 718) of the subjects had lateonset T2DM (mean age at diagnosis, 55 ± 6). The BMI and all clinical serology parameters we investigated were not significantly different between earlyand late-onset T2DM subjects (Table 3) . We compared the allelic and genotypic frequencies of ABCA1 gene polymorphisms in the Taiwanese T2DM patients with the information regarding the populations of Han Chinese in Beijing, extracted from the HapMap database (www.broadinstitute.org/ haploview, ver.4.2). The ABCA1 gene polymorphisms in the Taiwanese T2DM patients were not statistically different from those in the normal Han Chinese in Beijing population. Further, we classified the T2DM patients on the basis of age of onset to determine whether ABCA1 genes were associated with the early-onset phenotype. In genotype association tests, the polymorphisms at SNP rs10121901 in ABCA1 were statistically associated with earlyonset T2DM (p = 0.0347). Furthermore, in allelic frequency analysis, the frequency of the G allele at position rs10121901 was significantly lower in patients with early-onset T2DM than in those with late-onset T2DM, with an OR of 0.78 (95% CI: 0.64, 0.95) in a univariate model (Table 4) . After adjusting for gender and diabetes duration, the results were still significant (OR = 0.78, 95% CI = 0.64-0.96).
DISCUSSION
ABCA1 is an efficient exporter of cholesterol from cells and a major determinant of plasma HDL levels. Several ABCA1 polymorphisms and mutations have been reported to be associated with HDL cholesterol levels 16, 17 obesity 16 , and T2DM 20, 21 , across multiple ethnic groups [16] [17] [18] [19] [20] [21] . In this study, we investigated the influence of polymorphisms in the ABCA1 genes on HDL levels, BMI, and age of disease onset among T2DM patients. Previous studies have shown how ABCA1 polymorphisms influence HDL-cholesterol levels in diabetes patients 24 and in the general population 16, 19, [25] [26] [27] [28] . One of the well-studied variants with documented corresponding lipid profiles is rs2230806 (R219K); however, the results are inconsistent across various studies. Some studies show that the minor allele likely is associated with a decreased HDL level; other studies show the protective effect of a minor allele. In our present study, we did not find any association of the rs2230806 variant with any parameter of lipid profiles. We did identify a significant association between HDL level and rs2487039, which is highly linked with rs2230806. One possible factor explaining this contradictory conclusion is the different allele frequency among different ethnic groups. From a meta-analysis 29 , the 219K allele was significantly associated with a higher level of HDL-C in Asians but not in Caucasians. Furthermore, an interaction between the ABCA1 gene and BMI that could modulate HDL-cholesterol concentrations has been suggested 28 . We therefore investigated the possible interactions between the ABCA1 gene and BMI that could affect HDL-cholesterol, but no significant interaction was found (p > 0.05) for interaction terms of genotype*BMI. Additionally, a significant genotype effect on HDL-cholesterol was still observed after adjusting for BMI.
Inappropriate accumulation of cholesterol leads to obesity, atherosclerosis, and diabetes. ABCA1 is thought to mediate cholesterol efflux and plays an important role in maintaining cellular cholesterol homeostasis 30 . Insulin mediates the down-regulation of ABCA1 expression in adipocytes, but down-regulation continues in adipocytes that are insulin-resistant 28, 31 . In overweight subjects, who are usually hyperinsulinemic 32 , ABCA1 is more down-regulated than in normal-weight subjects 28 . In this cross sectional study, we found an association of ABCA1 gene variants with BMI in T2DM patients, and this result is consistent with previous studies. Villarreal-Molina et al 16 found an association of the ABCA1 R230C variant with BMI, and obesity-related comorbidity was observed in the Mexican mestizo general population. Xu et al 33 also found the expression of ABCA1 was reduced in overweight and obese patients and was related to a lower circulating level of the adipokine, adiponectin. Furthermore, abnormal cellular cholesterol in pancreatic beta-cells may contribute to betacell dysfunction, and ABCA1 activity is one of the important determinants of intracellular cholesterol content. Altered intracellular cholesterol homeostasis and impaired insulin secretion were observed in mice with beta-cell dysfunction for ABCA1 15 . Subjects carrying loss-of-function mutations in ABCA1 show impaired insulin secretion but not insulin resistance 34, 35 . In our present study, a significant association was identified between polymorphisms within ABCA1 SNP found that the ABCA1 R230C variant is associated with early-onset T2DM in the Mexican population.
The maximum allele frequency of the R230C variant however is less than 5% for the population in our study. We therefore investigated the association between SNP rs2230806, which is grouped by LD with rs9282541, and the age of onset of T2DM, but we did not find a significant result.
The results obtained in the present study have some limitations. First, information on age of onset was based on self-report questionnaires and was not validated by physicians; therefore, there could be an overestimated or underestimated bias. In addition, we only examined four polymorphisms, which do not represent all possible genetic variations of the ABCA1 gene. Moreover, most of the previous studies have been conducted in non-Asian countries, and some previously examined polymorphisms (such as the ABCA1 R230C polymorphism) have very low frequencies among the Han Chinese population. Thus common polymorphisms in other populations could not be evaluated in our study. Further studies with a larger number of subjects in a more diverse population, especially Asian populations, are therefore needed to conclusively elucidate the association between genetic polymorphisms in ABCA1 and different diabetic phenotypes. Functional analyses are also required to further characterize the role of ABCA1 variation in the pathogenesis of T2DM. In conclusion, the findings of our study show that polymorphisms in the ABCA1 gene are statistically associated with BMI and early-onset T2DM in a specific Taiwanese www.scienceasia.org population.
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